Anticoagulant Clinical Trials

40 recruitingLast updated: June 20, 2026

There are 40 actively recruiting anticoagulant clinical trials across 18 countries. Studies span Not Applicable, Phase 4, Phase 3, Phase 1, Phase 2. Top locations include Beijing, Beijing Municipality, China, Salt Lake City, Utah, United States, Moscow, Russia. Updated daily from ClinicalTrials.gov.


Anticoagulant Trials at a Glance

40 actively recruiting trials for anticoagulant are listed on ClinicalTrialsFinder across 6 cities in 18 countries. The largest study group is Not Applicable with 10 trials, with the heaviest enrollment activity in Beijing, Salt Lake City, and Moscow. Lead sponsors running anticoagulant studies include Brigham and Women's Hospital, Centre Hospitalier Régional d'Orléans, and Arianna Anticoagulazione Foundation.

Browse anticoagulant trials by phase

Treatments under study

About Anticoagulant Clinical Trials

Looking for clinical trials for Anticoagulant? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Anticoagulant trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Anticoagulant clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 40 trials

Recruiting
Phase 4

AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE

Atrial FibrillationStrokePlatelet Aggregation Inhibitors+2 more
University Hospital, Bordeaux60 enrolled2 locationsNCT04796714
Recruiting
Not Applicable

Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation

StrokeFrailtyAtrial Fibrillation (AF)+4 more
Guangdong Provincial People's Hospital200 enrolled1 locationNCT07441382
Recruiting
Not Applicable

Comparison Between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary Intervention

Atrial FibrillationCoronary Artery DiseaseAnticoagulants
Zuyderland Medisch Centrum1,270 enrolled1 locationNCT04977076
Recruiting
Phase 4

Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

Cardiovascular DiseasesVenous ThromboembolismPulmonary Embolism+6 more
Drahomir Aujesky276 enrolled40 locationsNCT04263038
Recruiting

International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants

ThrombosisAntiphospholipid SyndromeAnticoagulants Causing Adverse Effects in Therapeutic Use
Stéphane Zuily500 enrolled1 locationNCT04262492
Recruiting

CLOT-LESS - CLOsure Tailored: LEss Antithrombotic Strategy After LAAC for Stroke Prevention

Atrial FibrillationThromboembolismLeft Atrial Appendage Closure+4 more
National Medical Research Center for Therapy and Preventive Medicine464 enrolled1 locationNCT07575867
Recruiting
Not Applicable

Effect of Apiban Therapy on AVF Maturation in ESRD Patients

Arteriovenous FistulaDirect Oral Anticoagulants (DOACs)Endstage Renal Disease+1 more
Combined military hospital lahore190 enrolled1 locationNCT07559942
Recruiting
Not Applicable

COOLEY- Study: aCute On chrOnic Liver failurE Using the cYtosorb Device

SarcopeniaUltrasonographyAcute-On-Chronic Liver Failure+1 more
University Hospital, Antwerp20 enrolled1 locationNCT06079021
Recruiting
Phase 4

Vitamin K for Perioperative Warfarin Management

Anticoagulant Therapy
University of Michigan20 enrolled1 locationNCT07515664
Recruiting

Oral Biopsy Bleeding in Patients on Direct Oral Anticoagulants (DOACs)

Oral Surgical ProceduresDirect Oral Anticoagulants (DOACs)
University of Pisa100 enrolled1 locationNCT07520890
Recruiting
Phase 2

IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy

Pregnancy ComplicationsHigh Risk PregnancyAntiphospholipid Syndrome in Pregnancy+1 more
David Ware Branch55 enrolled3 locationsNCT03152058
Recruiting
Not Applicable

Home Hospital for Suddenly Ill Adults

Heart FailureAsthmaChronic Kidney Diseases+6 more
Brigham and Women's Hospital3,000 enrolled2 locationsNCT03524222
Recruiting
Not Applicable

Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP)

Benign Prostatic HyperplasiaAnticoagulant Adverse Reaction
Clinique Pasteur389 enrolled1 locationNCT03297281
Recruiting
Not Applicable

Atrial Fibrillation TRIal of Left Atrial Appendage Closure Using Seralene Hemostatic Suture

Atrial Fibrillation (AF)Stroke (in Patients With Atrial Fibrillation)ATRIAL APPENDAGE CLOSURE for ATRIAL FIBRILLATION+2 more
Institute of Cardiovascular Diseases, Vojvodina200 enrolled1 locationNCT07360899
Recruiting

Evaluation of the Cryocheck HexLA Integrated TCA for the Detection of Lupus Anticoagulant

Lupus Anticoagulant
University Hospital, Strasbourg, France200 enrolled1 locationNCT07313475
Recruiting

Hip Fracture Surgery Timing and Blood Transfusion Risk in Patients on DOACs

blood transfusionBlood Transfusion ComplicationBleeding+6 more
St. Antonius Hospital374 enrolled7 locationsNCT07309848
Recruiting
Not Applicable

Comparison of Heparin Anti-Xa Activity From Central Venous Catheter Samples Using a 5 mL Syringe Flush or a Vacuum Tube Flush Versus Peripheral Vein Samples in ICU Patients

Anticoagulants and Bleeding Disorders
Centre Hospitalier Régional d'Orléans30 enrolled1 locationNCT07183605
Recruiting
Phase 4

Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)

Pregnancy, High RiskAnticoagulants
University of California, Irvine12 enrolled1 locationNCT04861103
Recruiting

Ultrasound Evaluation of Hematoma Risk After Needle EMG in Patient on DOAC Therapy

Neuromuscular Diseases (NMD)PolyneuropathiesPeripheral Neuropathies+4 more
Masaryk University70 enrolled2 locationsNCT07166302
Recruiting
Phase 3

Thrombolysis in Factor Xa-inhibitors Trial

StrokeAcute Ischemic StrokeIschemic Stroke+6 more
Guri Hagberg300 enrolled13 locationsNCT06878066